Journal article
How can we improve our understanding of cardiovascular safety liabilities to develop safer medicines?
- Abstract:
-
Given that cardiovascular safety liabilities remain a major cause of drug attrition during preclinical and clinical development, adverse drug reactions, and post-approval withdrawal of medicines, the Medical Research Council Centre for Drug Safety Science hosted a workshop to discuss current challenges in determining, understanding and addressing 'Cardiovascular Toxicity of Medicines'. This article summarizes the key discussions from the workshop that aimed to address three major questions: (...
Expand abstract
- Publication status:
- Published
Actions
Authors
Bibliographic Details
- Journal:
- British journal of pharmacology
- Volume:
- 163
- Issue:
- 4
- Pages:
- 675-693
- Publication date:
- 2011-06-01
- DOI:
- EISSN:
-
1476-5381
- ISSN:
-
0007-1188
- Source identifiers:
-
118048
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:118048
- UUID:
-
uuid:4ff9f411-50fc-4741-af27-1a9a886dff83
- Local pid:
- pubs:118048
- Deposit date:
- 2012-12-19
Terms of use
- Copyright date:
- 2011
If you are the owner of this record, you can report an update to it here: Report update to this record